Heartflow, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$45.3M
41 notices · 1,165,725 sh
Reported ·
$146.2M
47 sales · 1 buy · $1,053,600 bought
42 of 47 reported sales carry the 10b5-1 box. Together they are 5.52% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
Nov 17Rogers Campbell, Chief Medical Officer$262,289
Nov 17Rogers Campbell, Chief Medical Officer$1,122,081
Nov 10Farquhar John C.M., Chief Executive Officer$2,168,286
Form 4, Nov 10: sold 38,900 at $55.74Includes the sale of 23,280 shares of common stock held and the option exercise and sale of 15,620 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12... Form 4 ↗
Nov 9Verghese Vikram, Chief Financial Officer$190,649
Form 4, Nov 10: sold 3,587 at $53.15The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026. Form 4 ↗
Oct 22Rogers Campbell, Chief Medical Officer$1,316,554
Form 4, Oct 26: sold 23,933 at $55.01Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 17,430 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. Form 4 ↗
Oct 22Rogers Campbell, Chief Medical Officer$311,027
Oct 12Farquhar John C.M., Chief Executive Officer$1,928,195
Form 4, Oct 14: sold 38,900 at $49.57The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Form 4 ↗
Sep 18Verghese Vikram, Chief Financial Officer$850,927
Sep 18Rogers Campbell, Chief Medical Officer$283,498
Sep 18Rogers Campbell, Chief Medical Officer$987,052
Form 4, Sep 21: sold 19,682 at $50.15Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026. Form 4 ↗
Sep 17Verghese Vikram, Chief Financial Officer$379,815
Form 4, Sep 18: sold 24,345 at $50.55The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026. Form 4 ↗
Sep 15Verghese Vikram, Chief Financial Officer$33,408
Sep 14Verghese Vikram, Chief Financial Officer$230,744
Sep 11Farquhar John C.M., Chief Executive Officer$194,500
Sep 11Verghese Vikram, Chief Financial Officer$1,487,460
Form 4, Sep 15: sold 34,975 at $50.08The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026. Form 4 ↗
Sep 10Farquhar John C.M., Chief Executive Officer$1,625,104
Sep 8Verghese Vikram, Chief Financial Officer$332,212
Form 4, Sep 10: sold 6,640 at $50.03The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026. Form 4 ↗
Sep 3Verghese Vikram, Chief Financial Officer$1,368,472
Sep 2Verghese Vikram, Chief Financial Officer$297,326
Form 4, Sep 4: sold 33,416 at $49.85The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026. Form 4 ↗
Aug 21Farquhar John C.M., Chief Executive Officer$1,361,500
Form 4, Aug 25: sold 27,230 at $50.00The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Form 4 ↗
Aug 18Farquhar John C.M., Chief Executive Officer$1,470,420
Form 4, Aug 20: sold 32,676 at $45.00 Form 4 ↗
Aug 17Rogers Campbell, Chief Medical Officer$380,099
Form 4, Aug 19: sold 9,219 at $41.23 Form 4 ↗
Aug 14Farquhar John C.M., Chief Executive Officer$607,774
Form 4, Aug 18: sold 15,560 at $39.06 Form 4 ↗
Aug 14Cohen Arthur Bruce, Affiliate of HCPCIV 1 LLC$8,434,000
Aug 14Healey Joseph Patrick, Affiliate of HCPCIV 1 LLC$6,225,000
Aug 10Farquhar John C.M., Chief Executive Officer$638,730
Form 4, Aug 12: sold 22,562 at $28.31 Form 4 ↗
Jul 15Rogers Campbell, Chief Medical Officer$237,113
Form 4, Jul 17: sold 9,219 at $25.72 Form 4 ↗
Jul 10Farquhar John C.M., Chief Executive Officer$626,096
Form 4, Jul 13: sold 22,562 at $27.75 Form 4 ↗
Jun 24Farquhar John C.M., Chief Executive Officer$1,361,500
Form 4, Jun 26: sold 38,900 at $35.00 Form 4 ↗
Jun 10Farquhar John C.M., Chief Executive Officer$643,017
Form 4, Jun 12: sold 22,562 at $28.50 Form 4 ↗
May 18Rogers Campbell, Chief Medical Officer$261,266
Form 4, May 20: sold 9,219 at $28.34 Form 4 ↗
May 11Farquhar John C.M., Chief Executive Officer$657,005
Form 4, May 13: sold 22,562 at $29.12 Form 4 ↗
Apr 10Farquhar John C.M., Chief Executive Officer$602,857
Form 4, Apr 14: sold 22,562 at $26.72 Form 4 ↗
Apr 1Rogers Campbell, Chief Medical Officer$1,589,935
Form 4, Apr 3: sold 64,533 at $24.64 Form 4 ↗
Mar 19Rogers Campbell, Chief Medical Officer$1,658,030
Form 4, Mar 23: sold 64,533 at $25.69 Form 4 ↗
Mar 18Farquhar John C.M., Chief Executive Officer$243,125
Form 4, Mar 20: sold 9,725 at $25.00 Form 4 ↗
Mar 10Farquhar John C.M., Chief Executive Officer$290,886
Form 4, Mar 12: sold 12,837 at $22.66 Form 4 ↗
Mar 5Cullivan Julie A, Director$228,050
Form 4, Mar 6: sold 9,122 at $25.00 Form 4 ↗
Feb 12Rogers Campbell, Chief Medical Officer$1,595,485
Form 4, Feb 17: sold 65,153 at $24.49 Form 4 ↗
Feb 10Farquhar John C.M., Chief Executive Officer$619,557
Form 4, Feb 10: sold 22,562 at $27.46 Form 4 ↗